← 홈

혈액암 (AML/ALL) · CD19

102개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-8 · 마지막 7월 21일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 102개
CGTBiologicstaleAllorunning TherapeuticsPhase 1

BCMA/CD19-targeted allogeneic CAR-T (BCMA/CD19-targeted allogeneic CAR-T)

Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma Patients Ineligible or Unwilling to Undergo ASCT; Newly Diagnose… · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleKang YUPreclinical

CAR-CD19 T cell (CAR-CD19 T cell)

B Cell Lymphoma; B Cell Leukemia · CD19

#CD19#CGT#Preclinical#세포유전치료#CAR-T+4
효능 ORR 67%임상시험 1상태 ACTIVE
CGTBiologicstaleShanghai Simnova Biotechnology …Phase 1

CAR-NK-CD19 Cells (CAR-NK-CD19 Cells)

Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+3
효능 ORR 0%임상시험 1상태 ACTIVE
CGTBiologicstaleSheba Medical CenterPhase 3

CAR-T CD19 (CAR-T CD19)

Acute Myeloid Leukemia · CD19

#CD19#CGT#Phase3#세포유전치료#CAR-T+3
효능 ORR 67%임상시험 1상태 ACTIVE
CGTBiologicstaleGuangdong Zhaotai Cell Bio-tech…Phase 2

CAT19T2 (CD19 CAR T-Cell, CD19 CAR T-Cell(CAT19T2))

B-cell Acute Lymphoblastic Leukemia; B-Cell Lymphoma, Unspecified · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 1상태 DISCONTINUED
CGTBiologicstaleThird Military Medical Universi…Phase 1

CD19 CAR and PD-1 knock out engineered T-cells (CD19 CAR and PD-1 knock out engineered T-cells)

Acute Lymphoblastic Leukemia; Burkitt Lymphoma · PD-1

#PD-1#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleSabz BiomedicalsPhase 1

CD19 CAR engineered autologous T-cells (CD19 CAR engineered autologous T-cells)

Relapsed B Cell Acute Lymphoblastic Leukemia (ALL); Refractory B Cell Acute Lymphoblastic Leukemia (ALL) · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleShanghai Unicar-Therapy Bio-med…Phase 2

CD19 CAR-T cells and CD19 positive feeder T cells (CD19 CAR-T cells and CD19 positive feeder T cells)

Acute Lymphoblastic Leukemia in Remission · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleShanghai Unicar-Therapy Bio-med…Phase 2

CD19 CAR-T cells with CRS suppression technology (CD19 CAR-T cells with CRS suppression technology)

Acute Lymphoblastic Leukemia; CD19 Positive · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleiCell Gene TherapeuticsPhase 1

CD19 CARvac T cells (CD19 CARvac T cells)

B Cell Lymphoma; B Cell Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleUniversity of Colorado, DenverPhase 1

CD19 Directed CAR T Cell (CD19 Directed CAR T Cell)

Acute Lymphoid Leukemia; Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleChongqing Precision Biotech Co.…Phase 2

CD19 and CD22 targeted prime CAR-T cells (CD19 and CD22 targeted prime CAR-T cells)

B-ALL · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
CGTBiologicstaleXuanwu Hospital, BeijingPhase 2

CD19 hsCAR-T (CD19 hsCAR-T)

Acute Lymphoblastic Leukemia · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
CGTBiologicstaleSouthwest Hospital, ChinaPhase 2

CD19 or CD20 CAR T cells briging HSCT (CD19 or CD20 CAR T cells briging HSCT)

Lymphoma, Large B-Cell, Diffuse; Leukemia, Lymphocytic, Chronic, B-Cell · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+5
임상시험 1상태 ACTIVE
CGTBiologicstaleNationwide Children's HospitalPhase 1

CD19 specific Chimeric Antigen Receptor T Cell (CD19 specific Chimeric Antigen Receptor T Cell)

Acute Lymphoblastic Leukemia, in Relapse; Non-Hodgkin's Lymphoma, Relapsed · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+5
임상시험 1상태 RECRUITING
CGTBiologicstaleHebei Taihe Chunyu Biotechnolog…Phase 2

CD19&CD22 bispecific CAR-T cells (CD19&CD22 bispecific CAR-T cells)

B-Cell Lymphoblastic Leukemia/Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING
CGTBiologicstaleSt. Jude Children's Research Ho…Phase 2

SJCAR19 product (CD19- specific CAR engineered autologous T-cells, CD19- specific CAR engineered autologous T-cells (SJCAR19 product))

Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia, Refractory · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
효능 ORR 20%임상시험 1상태 RECRUITING
CGTBiologicstaleSt. Jude Children's Research Ho…Phase 1

CD19-CAR (Mem, CD19-CAR, CD19-CAR(Mem) T-cells)

Acute Lymphoblastic Leukemia, in Relapse; Acute Lymphoblastic Leukemia, Refractory · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
효능 ORR 67%임상시험 1상태 RECRUITING
CGTBiologicstalePersonGen BioTherapeutics (Suzh…Phase 1

CD19-CART (CD19-CART)

B Acute Lymphoblastic Leukemia; Mantle Cell Lymphoma · CD19

#CD19#CGT#Phase1#세포유전치료#CAR-T+4
임상시험 1상태 ACTIVE
CGTBiologicstaleBambino Gesù Hospital and Resea…Phase 2

CD19-CAR_Lenti T cell (CD19-CAR_Lenti T cell)

Acute Lymphoblastic Leukemia; Diffuse Large B Cell Lymphoma · CD19

#CD19#CGT#Phase2#세포유전치료#CAR-T+4
임상시험 1상태 RECRUITING

3 / 6 페이지

← 이전다음 →